Belando, Roselyn .
HRN: 27-37-09 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 500MG (TAB)
06/24/2025
07/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness
06/25/2025
CEFUROXIME 1.5GM (VIAL)
06/25/2025
06/26/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness
06/25/2025
CEFUROXIME 1.5GM (VIAL)
06/25/2025
06/26/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness